(259 days)
Not Found
No
The description focuses on standard Doppler and APPG technology for detecting blood flow and fetal heart rate, with no mention of AI or ML algorithms for analysis, interpretation, or prediction. The software component is described as a medical device data system (MDDS) for displaying, archiving, and printing waveforms, not for advanced analysis.
No
The device is indicated for non-invasive assessment of vascular blood flow and fetal heart rate to assist in diagnosis, which means it aids in identifying conditions rather than treating them.
Yes
Explanation: The "Intended Use / Indications for Use" section explicitly states that the devices (DMX and SRX Handheld Dopplers) are used "to assist in diagnosis."
No
The device description clearly details hardware components such as a hand unit, probes (Doppler and APPG), a display, buttons, a loudspeaker, and internal batteries. While it mentions optional software (DR5), this software is described as an accessory that can only be used with the hardware device and is not a standalone medical device. The performance studies also include hardware testing.
Based on the provided information, this device is NOT an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information about a person's health.
- Device Function: The DMX and SRX Handheld Dopplers use non-invasive methods (ultrasound and infrared light) applied to the body to assess vascular blood flow and fetal heart rate. They do not analyze samples taken from the body.
- Intended Use: The intended use clearly states "non-invasive assessment" and "assessment of fetal heart rate," which are procedures performed directly on the patient, not on a specimen.
Therefore, the DMX and SRX Handheld Dopplers fall under the category of medical devices used for diagnosis and monitoring in vivo (within the living body), not in vitro.
N/A
Intended Use / Indications for Use
The DMX Handheld Doppler:
Indicated for use by qualified healthcare practitioners in primary, acute and community healthcare environments, for the non-invasive assessment of vascular blood flow to assist in diagnosis.
The SRX Handheld Doppler:
Indicated for use by qualified healthcare practitioners in primary, acute and community healthcare environments, for the assessment of fetal heart rate to assist in diagnosis.
Product codes (comma separated list FDA assigned to the subject device)
DPW, DXO, JOM, JAF, HGL, KNG
Device Description
The DMX Doppler provides the clinician with the ability to perform vascular investigations. It is powered from two internal replaceable AA format 1.5 volt alkaline or 1.2 volt NiMH rechargeable batteries. The DMX hand unit is used with a Doppler or Arterial Photoplethysmography (APPG) probe, selected to suit the nature of the investigation to be performed.
The device includes a colour liquid crystal display and three soft keys for user input. Doppler audio sounds are reproduced by the integral loudspeaker; the audio level can be adjusted by two buttons.
Doppler Mode:
The probes emit low energy ultrasonic waves into the body which are reflected back into the probe. The reflected ultrasonic waves contain information about the blood flow, which can be heard as audio sounds from the loudspeaker and waveforms presented on the display. There is a range of compatible Doppler probes; the choice of probe is determined by the type of vascular assessment being performed and depth of vessel.
APPG Mode:
The APPG sensor emits low energy infra-red light into the body, some of which is reflected by blood within the tissue back into the sensor. The variation of this reflected light is related to the blood volume within the tissue. The APPG probe is used with an inflatable cuff and sphygmomanometer gauge to measure toe / finger blood pressures.
Doplex Reporter 5 (DR5) Software Package:
The DR5 software is a medical device data system (MDDS) and is an optional accessory to the dopplex® DMX bidirectional Doppler. It can display bidirectional velocity/time waveforms obtained from various vessels. Data can be archived and a printout can be obtained for patients notes. The DR5 is not a standalone medical device – it can only be used with the DMX Doppler to display, archive and print Doppler waveforms and PPG pressures produced by the DMX.
The SRX Doppler range is intended to be used by qualified healthcare practitioners for the detection and presentation of the fetal heart rate to assist in the assessment of fetal well-being during pregnancy.
Each model is powered from two internal replaceable AA format 1.5 volt alkaline or 1.2 volt NiMH rechargeable batteries. The SRX hand unit is used with a choice of either a 2MHz (OP2XS) or 3MHz (OP3XS) obstetric Doppler probe. The SR2 and SR3 have fixed probes (2MHz and 3MHz respectively).
All models include a colour liquid crystal display and three soft keys for user input. Doppler audio sounds are reproduced by the integral loudspeaker; the audio level can be adjusted by two buttons.
The probes emit low energy ultrasonic waves into the body some of which are reflected back into the probe. The reflected ultrasonic waves contain information about the fetal heart, which can be heard as audio sounds from the loudspeaker and heart rate values presented on the display.
The DMX / SRX hand held Dopplers and Probes consist of an internally powered ‘monitor' with either primary cells or rechargeable (determined as a purchase option), these are used to create the various internal voltages required to drive the colour 240 x 320 pixel TFT LCD, the microprocessor, analogue electronics, audio amplifier and probe.
All versions of the DMX/SRX provide audio representation of the Doppler signal via and audio amplifier and internal speaker, with the ability to connect headphones via a 3.5mm jack socket.
The range of DMX / SRX compatible Huntleigh Doppler probes contain all the transmit (piezo transducer excitation) and receive electronics; the output from the probes are two analogue signals in phase quadrature which are fed into the DMX / SRX for processing.
The APPG probe includes an optical sensor which contains an infra red light emitting diode (LED) and photo transistor. The LED output is modulated at 1 kHz. The phototransistor output feeds into an amplifier that is synchronous with the LED drive signal, which helps to reduce the effect of ambient light. The amplified signal is bandpass filtered before being fed to the monitor unit. This signal represents relative blood volume changes, and is not calibrated.
Located inside the APPG module is an air pressure measurement sensor which records the instantaneous cuff pressure. The cuff pressure values are presented on the DMX display allowing the user to determine the actual systolic blood pressure.
All versions of the DMX / SRX range have the same internal hardware; the determination whether it is a 'Vascular' DMX or one of the 'Obstetric' SRX, SR2* or SR3* models is determined by a single 'link' on the main PCB, and external labels.
*The SR2 and SR3 models are also determined by having fixed 'Obstetric' Doppler probes.
The probes used with DMX and SRX models can be easily interchanged by the user.
The DMX version is a ‘Vascular' investigation device. Connecting one of a range of vascular Doppler probes sets the DMX to vascular Doppler mode and connecting the APPG probe sets the DMX to Photoplethysmography mode. It is possible to connect an Obstetric Doppler probe to the DMX which will provide full obstetric functionality.
The SRX version is an 'Obstetric' investigation device. Connecting either of the available Obstetric Doppler probes sets the SRX to Obstetric mode. It is possible to connect a vascular Doppler probe which will provide an audio only Doppler output.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Doppler Ultrasound, Infrared Photoplethysmography (PPG)
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
qualified healthcare practitioners in primary, acute and community healthcare environments
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing to demonstrate substantial equivalence included:
- Biocompatibility Testing: The biocompatibility evaluation of the device was conducted in accordance with ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process. The subject device is considered a skin contacting device (intact) for a duration of
§ 870.2100 Cardiovascular blood flowmeter.
(a)
Identification. A cardiovascular blood flowmeter is a device that is connected to a flow transducer that energizes the transducer and processes and displays the blood flow signal.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
September 6, 2019
Huntleigh Healthcare Ltd Steve Monks Quality Manager 35 Portmanmoor Road Cardiff, CF24 5HN United Kingdom
Re: K183574
Trade/Device Name: DMX/SRX Handheld Doppler and Probes Regulation Number: 21 CFR 870.2100 Regulation Name: Cardiovascular Blood Flowmeter Regulatory Class: Class II Product Code: DPW, DXO, JOM, JAF, HGL, KNG Dated: August 14, 2019 Received: August 19, 2019
Dear Steve Monks:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Stephen Browning Assistant Director Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K183574
Device Name DMX / SRX Handheld Doppler and Probes
Indications for Use (Describe) The DMX Handheld Doppler:
Indicated for use by qualified healthcare practitioners in primary, acute and community healthcare environments, for the non-invasive assessment of vascular blood flow to assist in diagnosis.
The SRX Handheld Doppler:
Indicated for use by qualified healthcare practitioners in primary, acute and community healthcare environments, for the assessment of fetal heart rate to assist in diagnosis.
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary DMX / SRX Handheld Doppler and Probes
| Name & Address: | Huntleigh Healthcare Limited - Diagnostic Products Division
Unit 35, Portmanmoor Road
Cardiff
CF24 5HN
United Kingdom |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------|
| Telephone: | +44 (0)2920 485885 |
| Fax: | +44 (0)2920 492520 |
| Prepared: | July 2019 |
| Contact: | Steve Monks |
Huntleigh Healthcare Limited • Diagnostic Products Division • 35 Portmanmoor Road • Cardiff • CF24 5HN • United Kingdom Tel: +44 (0)29 2048 5885 • Fax: +44 (0)29 2049 2520 • Mail: sales@huntleigh-diagnostics.co.uk • www.huntleigh-diagnostics.com VAT Reg: GB 382 474 630 • Registered No: 942245 England & Wals: Registered Office: ArjoHuntleigh House, Houghton Regis, Bedfordshire, LU5 SXF
AN ARJOHUNTLEIGH COMPANY, MEMBER OF THE GETINGE GROUP
4
| Device Name: | DMX / SRX Handheld Doppler and Probes | ||
|---|---|---|---|
| Common Name | |||
| (DMX / Vascular | |||
| Use) | Cardiovascular Blood Flowmeter / Non-Fetal Ultrasonic | ||
| Monitor / Hydraulic, pneumatic, photoelectric plethysmographs | |||
| / Transducer, ultrasonic, obstetric / Blood pressure cuff | |||
| Classification | |||
| (DMX / Vascular | |||
| Use) | Class | Product | |
| Code | Classification Regulation | ||
| II | |||
| II | |||
| II | |||
| II | |||
| II | DPW | ||
| JAF | |||
| JOM | |||
| HGL | |||
| DXQ | 870.2100 | ||
| 892.1540 | |||
| 870.2780 | |||
| 884.2960 | |||
| 870.1120 | |||
| Classification | |||
| Name: | |||
| (DMX / Vascular | |||
| Use) | Flowmeter, Blood, Cardiovascular | ||
| Predicate Devices: | |||
| (DMX / Vascular | |||
| Use) | MD2 family of Handheld vascular and obstetric Dopplers and | ||
| probes (HS range) manufactured by Huntleigh Healthcare | |||
| (K930200) | |||
| Vascular Assist manufactured by Huntleigh Healthcare | |||
| (K002186) | |||
| Indications for | |||
| Use: | |||
| (DMX / Vascular | |||
| Use) | Indicated for use by qualified healthcare practitioners in primary, | ||
| acute and community healthcare environments, for the non- | |||
| invasive assessment of vascular blood flow to assist in | |||
| diagnosis. | |||
| Description : | |||
| (DMX / Vascular | |||
| Use) | The DMX Doppler provides the clinician with the ability to | ||
| perform vascular investigations. It is powered from two internal | |||
| replaceable AA format 1.5 volt alkaline or 1.2 volt NiMH | |||
| rechargeable batteries. The DMX hand unit is used with a | |||
| Doppler or Arterial Photoplethysmography (APPG) probe, | |||
| selected to suit the nature of the investigation to be performed. |
The device includes a colour liquid crystal display and three soft
keys for user input. Doppler audio sounds are reproduced by
the integral loudspeaker; the audio level can be adjusted by two
buttons.
Doppler Mode:
The probes emit low energy ultrasonic waves into the body
which are reflected back into the probe. The reflected ultrasonic
waves contain information about the blood flow, which can be
heard as audio sounds from the loudspeaker and waveforms
presented on the display. There is a range of compatible
Doppler probes; the choice of probe is determined by the type
of vascular assessment being performed and depth of vessel. | | |
5
APPG Mode:
| The APPG sensor emits low energy infra-red light into the body, some of which is reflected by blood within the tissue back into the sensor. The variation of this reflected light is related to the blood volume within the tissue. The APPG probe is used with an inflatable cuff and sphygmomanometer gauge to measure toe / finger blood pressures. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Dopplex Reporter 5 (DR5) Software Package: | ||||||||||
| The DR5 software is a medical device data system (MDDS) and is an optional accessory to the dopplex® DMX bidirectional Doppler. It can display bidirectional velocity/time waveforms obtained from various vessels. Data can be archived and a printout can be obtained for patients notes. The DR5 is not a standalone medical device – it can only be used with the DMX Doppler to display, archive and print Doppler waveforms and PPG pressures produced by the DMX. | ||||||||||
| Note: Being an MDDS, the device is exempt from premarket notification and a letter to file against K930200/S2 will be completed, detailing the update in software version, of the already registered Dopplex Reporter Software package. | ||||||||||
| Models: | ||||||||||
| (DMX / Vascular | ||||||||||
| Use) | There are two vascular versions: | |||||||||
| DMX (non-rechargeable version) | ||||||||||
| DMXR (rechargeable version) | ||||||||||
| The DMXR is contained in two different Vascular assessment kits: | ||||||||||
| DMXRABI – Ankle Brachial Index Kit | ||||||||||
| DMXRATP – Ankle and Toe Pressure kit | ||||||||||
| The vascular probes include: | ||||||||||
| VP4XS - 4MHz Vascular Doppler Probe | ||||||||||
| VP5XS - 5MHz Vascular Doppler Probe | ||||||||||
| VP8XS - 8MHz Vascular Doppler Probe | ||||||||||
| EZ8XS - 8MHz Widebeam Vascular Doppler Probe | ||||||||||
| VP10XS - 10MHz Vascular Doppler Probe | ||||||||||
| PPGA1 - Photoplethysmography Probe | ||||||||||
| Common Name | ||||||||||
| (SRX /Obstetric | ||||||||||
| Use) | Fetal ultrasonic Monitor and accessories / Obstetric Ultrasonic Transducer | |||||||||
| Classification | ||||||||||
| (SRX /Obstetric | ||||||||||
| Use) | ClassProduct CodeClassification RegulationIIKNG884.2660IIHGL884.2960 | Class | Product Code | Classification Regulation | II | KNG | 884.2660 | II | HGL | 884.2960 |
| Class | Product Code | Classification Regulation | ||||||||
| II | KNG | 884.2660 | ||||||||
| II | HGL | 884.2960 |
6
| Classification
Name:
(SRX /Obstetric
| Use) | Fetal ultrasonic Monitor and accessories |
|---|---|
| Predicate Devices: | |
| (SRX /Obstetric | |
| Use) | MD2 family of Handheld vascular and obstetric Dopplers and |
| probes (HS range) manufactured by Huntleigh Healthcare | |
| (K930200) | |
| Indications for | |
| Use: | |
| (SRX /Obstetric | |
| Use) | Indicated for use by qualified healthcare practitioners in primary, |
| acute and community healthcare environments, for the | |
| assessment of fetal heart rate to assist in diagnosis. | |
| Description : | |
| (SRX /Obstetric | |
| Use) | The SRX Doppler range is intended to be used by qualified |
| healthcare practitioners for the detection and presentation of the | |
| fetal heart rate to assist in the assessment of fetal well-being | |
| during pregnancy. | |
| Each model is powered from two internal replaceable AA format | |
| 1.5 volt alkaline or 1.2 volt NiMH rechargeable batteries. The | |
| SRX hand unit is used with a choice of either a 2MHz (OP2XS) | |
| or 3MHz (OP3XS) obstetric Doppler probe. The SR2 and SR3 | |
| have fixed probes (2MHz and 3MHz respectively). | |
| All models include a colour liquid crystal display and three soft | |
| keys for user input. Doppler audio sounds are reproduced by | |
| the integral loudspeaker; the audio level can be adjusted by two | |
| buttons. | |
| The probes emit low energy ultrasonic waves into the body | |
| some of which are reflected back into the probe. The reflected | |
| ultrasonic waves contain information about the fetal heart, | |
| which can be heard as audio sounds from the loudspeaker and | |
| heart rate values presented on the display. | |
| Models: | |
| (SRX /Obstetric | |
| Use) | There are six obstetric versions: |
| SRX (non-rechargeable version) interchangeable probe | |
| capable | |
| SRXR (rechargeable version) interchangeable probe capable | |
| SR2 fixed 2MHz probe (non-rechargeable) | |
| SR2R fixed 2MHz probe (rechargeable) | |
| SR3 fixed 3MHz probe (non-rechargeable) | |
| SR3R fixed 3MHz probe (rechargeable) | |
| The obstetric probes include: | |
| OP2XS – 2MHz Obstetric Doppler Probe | |
| OP3XS – 3MHz Obstetric Doppler Probe | |
| Comparison of | |
| Technological | Doppler Ultrasound and Infrared Photoplethysmography (PPG) |
| are the technological principles for both the subject and |
7
Characteristics with Predicate Devices (DMX — Vascular Use)
predicate devices. It is based on the combination of a handheld 'monitor' and a cable attached Doppler probe or PPG probe, changing the probe changes the functionality of the monitor to the corresponding mode.
DOPPLER MODE (selected automatically by fitting a Doppler probe):
The subject and the predicate (Huntleigh MD2) are based on the following same technological elements:
- The monitor provides the power to the probe ●
- The monitor and probes have a probe identification (ID) system
- . The monitor provides a Doppler signal audio output via internal loudspeaker or optional headphones
- The monitor performs filtering of the Doppler signal
- . The monitors have LCD displays
- . The monitor displays the Probe frequency
- The monitors are available either with rechargeable or primary batteries
- The monitor provides a graphical battery power level indication
- . The Doppler probes are functionally identical
The following technological differences exist between the subject device and predicate (Huntleigh MD2) device:
- The subject device displays the 'Maximum Frequency' . flowrate waveform for forward and reverse blood flow: the predicate displays flowrate as a bar graph (4 levels in each direction)
- . The subject device can store multiple blood flow waveforms that can be recalled and played back; the predicate does not have this capability.
- The subject device has a 320 x 240 Pixel Colour Graphic ● LCD, whereas the predicate has a fixed character monochrome LCD.
- The subject has a USB interface whereas the predicate has an RS232 interface
- The user controls of the subject device are 'soft keys', ● the function of which is identified by the LCD whereas the predicate has 'fixed' function buttons
- . Audio volume of the subject device is controlled by an up and a down button, whereas the predicate uses a rotary volume control
8
APPG MODE (selected automatically by fitting an APPG probe):
The subject device and the predicate (Huntleigh Vascular Assist) are based on the same following technological elements:
- The device can store multiple APPG waveforms and pressures that can be recalled, displayed and 'replayed'.
- The monitor provides the power to the probe ●
- . The monitor and probe have a probe identification (ID) system
- The subject and predicate have colour LCD displays
The following technological differences exist between the subject device and predicate (Huntleigh Vascular Assist) device:
- The subject LCD is smaller than the predicate ●
- The subject can operate on either rechargeable battery or primary battery; the predicate can only operate on rechargeable battery.
- The subject has a USB interface whereas the predicate has an RS232 interface
Comparison of Technological Characteristics with Predicate Devices (SRX - Obstetric Use)
Doppler Ultrasound is the technological principle for both the subject and predicate devices. It is based on the combination of a handheld 'monitor' and a cable attached Doppler probe.
The subject and the predicate (Huntleigh MD2) are based on the following same technological elements:
- The monitor provides the power to the probe ●
- . The monitor and probes have a probe identification (ID) system
- The monitor provides a Doppler signal audio output via ● internal loudspeaker or optional headphones
- The monitor performs filtering of the Doppler signal
- The monitors have LCD displays ●
- The monitor displays the Probe frequency
- . The monitors are available either with rechargeable or primary batteries
- The monitor provides a graphical battery power level indication
- The Doppler probes are functionally identical
The following technological differences exist between the
9
| subject device and predicate (Huntleigh MD2) device: | |||||||
|---|---|---|---|---|---|---|---|
| • | The subject device can display fetal heart rate in | ||||||
| numerical format and graphically, whereas the predicate | |||||||
| can only display fetal heartrate numerically. | |||||||
| • | The subject device can store multiple fetal heartrate | ||||||
| traces that can be recalled, displayed and replayed, | |||||||
| which the predicate cannot. | |||||||
| • | The subject device has a 320 x 240 Pixel Colour Graphic | ||||||
| LCD, whereas the predicate has a fixed character | |||||||
| monochrome LCD. | |||||||
| • | The subject device has a USB interface, whereas the | ||||||
| predicate has an RS232 interface | |||||||
| • | The user controls of the subject device are 'soft keys', | ||||||
| the function of which is identified by the LCD, whereas | |||||||
| the predicate has 'fixed' function buttons | |||||||
| • | Audio volume of the subject device is controlled by an up | ||||||
| and a down button, whereas the predicate uses a rotary | |||||||
| volume control | |||||||
| Substantial | |||||||
| Equivalence: | |||||||
| Performance | |||||||
| Data: | The DMX / SRX Handheld Dopplers and Probes are | ||||||
| substantially equivalent to the cleared devices Huntleigh MD2 | |||||||
| and probes (K930200) and Huntleigh Vascular Assist | |||||||
| (K002186) | |||||||
| Testing to demonstrate substantial equivalence included: | |||||||
| Testing Conducted Discussion Biocompatibility Testing | |||||||
| -Cytotoxicity | |||||||
| -Sensitization | |||||||
| -Irritation The biocompatibility evaluation of | |||||||
| the device was conducted in | |||||||
| accordance with ISO 10993- | |||||||
| 1:2009 Biological evaluation of | |||||||
| medical devices - Part 1: | |||||||
| Evaluation and testing within a | |||||||
| risk management process. The | |||||||
| subject device is considered a | |||||||
| skin contacting device (intact) for | |||||||
| a duration of |